Two Top Stocks to Keep an Eye on: Mitel Networks Corporation (NASDAQ:MITL), China Cord Blood Corporation (NYSE:CO)

Mitel Networks Corporation (NASDAQ:MITL)

The shares of Mitel Networks Corporation (NASDAQ:MITL) started off the last trading session with the price of $9.17 while closing the day with the price of $9.2. The shares of Mitel Networks Corporation (NASDAQ:MITL) Rise 0.88% with the Gain of 0.03 points.

The shares of Mitel Networks Corporation (NASDAQ:MITL) traded with the day volume of 1.23 Million shares whereas its average trading volume is 1.27 Million.

While analyzing the past performance of the stock we can see that the shares of Mitel Networks Corporation (NASDAQ:MITL) Gain 7.1% in the last week while rising 5.14% in the last month. Past quarter performance shows the green light with 25.17%. The semi-annual and annual performance shows 13.16% and 28.13% respectively.

Some critical values of the shares of Mitel Networks Corporation (NASDAQ:MITL) to be discussed here are: the beta which shows the value at 2.61 while Average True Range of Mitel Networks Corporation (NASDAQ:MITL) demonstrate the value at 0.32. The weekly and monthly volatility of the shares of Mitel Networks Corporation (NASDAQ:MITL) are indicated at 3.14% and 3.73%. Also to discuss here is the Relative Strength Index or RSI which is depicted at 63.75.

While studying the financial position of the shares of Mitel Networks Corporation (NASDAQ:MITL), we can see that the Market capitalization of the company is at 1.09 Billion. The shares outstanding for the company is 118.98 Million and the shares float stands at 109.07 Million. The income of the company stand at -51200000 while the sales stand at 1.06 Billion.

Here are some critical ratios for a financial perspective: Earnings Per Share or EPS of the company stand at -0.43, Price to Earnings or P/E is at 0, Price to Sales P/S show the value of 1.03, the Return on Asset ROA stood at -0.036 and the Return on Equity ROE depicted at -0.146 while Return on Investment ROI is at -0.033.


China Cord Blood Corporation (NYSE:CO)

China Cord Blood Corporation (NYSE:CO) started its previous trading session at $11.44 and closed at $11.5 showing a Rise of 0.88 Percent.

The Company traded with an average Volume of 208.41 Million whereas, its Day Volume stood at 1.23 Million.

Looking at the performance of the stock, China Cord Blood Corporation (NYSE:CO) Gain 7.68% in the last week in its shares price and 11.76% in the last month. Quarterly performance shows a green of 8.08 Percent while Semi-Annual and Annual performances shows a -4.17 and 98.62 percent respectively.

Beta for China Cord Blood Corporation (NYSE:CO) stands at 0.9 while the ATR (average true range) is at 0.44. The Stock’s Weekly and Monthly Volatility is 3.28% and 4.19% respectively showing a RSI value of 71.92.

While studying the financial position of the shares of China Cord Blood Corporation (NYSE:CO), we can see that the Market capitalization of the company is at 1.37 Billion. The shares outstanding for the company is 119.43 Million and the shares float stands at 39.43 Million.

The Company generated an income of 34.9 Million and the sales of 136.3 Million in the Trailing Twelve Months period.

While analyzing the stock from technical aspects, Diluted Earnings per share stands at $0.38 a share. P/E (price to earnings) and P/S (price to sales) values are 30.67 and 10.08 respectively.

The Return on Assets stands at 0.043, ROE shows a value of 0.087 and ROI for China Cord Blood Corporation (NYSE:CO) is 0.078 as of Trailing Twelve Months period.

The following two tabs change content below.

Eldred Matthew

Eldred Matthew covers Healthcare Sector Company recent Press Releases news updates. He has three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

View all contributions by

Eldred Matthew covers Healthcare Sector Company recent Press Releases news updates. He has three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

Leave a Comment